(600299)"Bluestar Adisseo Company"Announcement on Key Operating Data for Q3 2026
Filed with SSE · Stock code 600299 · · 3 pages · Chinese
Summary by 6ix AI
The company reported a total revenue increase driven by strong sales in its methionine business and effective pricing strategies. The filing also notes a substantial increase in EBITDA rate, reflecting enhanced profitability during the quarter.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Story so far
Earlier from Bluestar Adisseo
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Receipt of Administrative Penalty Decision by the Deputy General Manager for Matters Unrelated to the Company
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Departure of the Chairman and Nomination of Director
- Announcement on Receipt of "Prior Notice of Administrative Penalty" by the Deputy General Manager for Matters Unrelated to the Company
Later from Bluestar Adisseo
- (600299)"Bluestar Adisseo Company"Announcement on Change of Accounting Firm
- (600299)"Bluestar Adisseo Company"Announcement on Changes in Senior Executives
- (600299)"Bluestar Adisseo Company"Announcement on Resolutions of the 21st Meeting of the 9th Board of Directors
- (600299)"Bluestar Adisseo Company"Notice on Convening the 2nd Extraordinary General Meeting in 2026
Follow Bluestar Adisseo into a list and get an email when it puts out news.
Follow Bluestar Adisseo